Spanish drug spending down by a fifth
This article was originally published in Scrip
Spanish spending on pharmaceuticals is down yet again. Figures from the Spanish health ministry reveal a 20% drop in spending in August compared with the same month last year. More cost saving measures applicable from July, including increased patient co-payments and the removal of products from the reimbursement list, contributed significantly to the decline, says the ministry.
You may also be interested in...
Insurers argue that better use of real world data and multiple pricing assessments could help lower drug prices in Germany.
To keep investors happy, companies will have to start showing that their high-priced advanced therapies offset costs elsewhere in the health care system.
To maintain high prices and avoid access restrictions, companies marketing advanced therapies will have to show payers that their products save money elsewhere in the healthcare system.